All In MedTech

Device Trial Radar · NCT06699095

Home Rehabilitation as Continuity of Care in MS

"Tele-riabilitazione in Sclerosi Multipla: continuità Terapeutica Domiciliare Dopo Trattamento di Neuro-riabilitazione Intensiva, Studio Randomizzato Controllato Con Piattaforma Integrata Per la Riabilitazione Del Disequilibrio"

Last checked: Nov 20, 2026Latest source record: Sep 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

20

Planned (sponsor's estimate)

Start

Nov 6, 2024

Primary completion

Nov 6, 2025

Study completion Nov 15, 2026

Sponsor

Lead sponsor
Fondazione I.R.C.C.S. Istituto Neurologico Carlo BestaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Istituto Auxologico Italiano; Fondazione Don Carlo Gnocchi ETS
First posted
Nov 21, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Single group
Masking
None
Primary purpose
Health services research
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RCT pilot study to evaluate adherence, satisfaction and feasibility in the use of a telemedicine station for balance rehabilitation in patients with multiple sclerosis. The platform is designed as a tool for maintenance rehabilitation in a home setting and not as an alternative to intensive treatment in hospital, and is therefore compared to maintenance treatment as usual (TAU) after intensive treatment.

Conditions

  • Multiple Sclerosis

Interventions

  • TelerehabilitationDevice

    Patients will perform a 12 weeks rehabilitation program through telemedicine at home after intensive rehabilitation in hospital. Balance rehabilitation program will be scheduled on the patients' need and ability to be performed three times a week with high levels of satisfaction and safety at home under remote control of the physical therapist.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. FeasibilityTime frame: Home rehabilitation, from the end of the intensive treatment to the follow up evaluation (12 weeks)

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • IRCCS Istituto Auxologico Italiano

    Milan, MI, Italy

  • Fondazione IRCCS Istituto Neurologico Carlo Besta

    Milan, MI, Italy

  • IRCCS Santa Maria nascente - Fondazione Don Gnocchi

    Milan, MI, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.